GoodRx Holdings (GDRX) Other Non-Current Liabilities (2019 - 2026)

GoodRx Holdings' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $8.7 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 25.79% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $8.7 million (up 25.79% YoY), while the FY2025 annual figure was $8.7 million, up 29.4% from the prior year.
• Other Non-Current Liabilities came in at $8.7 million for Q1 2026 at GoodRx Holdings, down from $8.7 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $9.6 million in Q2 2023 to a low of $4.7 million in Q1 2022.
• A 5-year average of $7.7 million and a median of $7.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities declined 25.09% in 2022 and surged 70.04% in 2023, its largest moves.
• GoodRx Holdings' Other Non-Current Liabilities stood at $7.6 million in 2022, then grew by 8.2% to $8.2 million in 2023, then retreated by 17.39% to $6.8 million in 2024, then gained by 29.4% to $8.7 million in 2025, then decreased by 0.56% to $8.7 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $8.7 million, $8.7 million, and $7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison